Adler F L, Adler L T
Transplantation. 1984 Oct;38(4):387-91.
Chimeras established by transferring spleen or lymph node cells from primed donors use donor-derived B lymphocytes in responses to the antigen used in priming of the donor, whereas cells of the recipient are used in responses to other antigens. Clonal dominance by donor cells lasts for at least 9 months. Treatment of newborn rabbits with the antigen used in priming the donors elicits copious production of antibody bearing the donor's allotypic markers in chimeras, but tolerance is induced in nonchimeric controls. Lasting and effective memory is also established in chimeras in the absence of immediate antigenic stimulation. This model for transplantation of allogeneic lymphoid cells into recipients matched with the donor for major histocompatibility antigens shows that priming of the donor facilitates the specific, effective, and enduring acquisition of immunocompetence in the recipient for the antigen used in priming the donor.
通过移植来自已致敏供体的脾脏或淋巴结细胞所建立的嵌合体,在对供体致敏所用抗原的应答中使用供体来源的B淋巴细胞,而受体细胞则用于对其他抗原的应答。供体细胞的克隆优势持续至少9个月。用供体致敏所用抗原处理新生兔,可在嵌合体中引发大量带有供体同种异型标记的抗体产生,但在非嵌合体对照中会诱导耐受性。在没有即时抗原刺激的情况下,嵌合体中也能建立持久有效的记忆。这种将同种异体淋巴细胞移植到与供体主要组织相容性抗原相匹配的受体中的模型表明,供体的致敏促进了受体针对供体致敏所用抗原特异性、有效且持久地获得免疫能力。